Abstract:Objective: To investigate the effects of alendronate on expression levels of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) mRNAs in bone tissues of femoral head of rats receiving long-term glucocorticoid administration, and to explore the effect and mechanism of alendronate in preventing glucocorticoid-induced femoral head necrosis. Methods: Totally 30 healthy adult SD rats were randomly divided into 3 groups: glucocorticoid group, alendronate group and blank control group. The glucocorticoid group and alendronate group were treated by intramuscular injection of prednisolone, 12.5 mg/kg, two times per week, and rats in the alendronate group were intragastrically administered with alendronate, 5 mg/kg weight at the same time, one time per week. The control group was treated only by the same volume of intramuscularly injected sodium chloride. After 4 weeks' intervention, osteoporosis and osteonecrosis of left femoral head were detected by HE staining, the total RNA of right femoral head bone tissue was extracted and the expression levels of OPG and RANKL mRNAs were examined by real-time quantitative polymerase chain reaction (RTQ-PCR). Results: The mortality of rats was 10% (1/10), 10% (1/10) and 0 (0/10) in glucocorticoid, alendronate and control groups. The osteoporosis and necrosis rates of femoral bone head were 66.67% (6/9), 22. 22% (2/9) and 0 (0/10) in the three groups, respectively. The level of OPG mRNA expression was 0.96±0.16, 1.35±0.26 and 1.60±0.49 in glucocorticoid, alendronate and control groups, while the expression of RANKL mRNA was 3.33±1.04, 1.98±0.51 and 1.58±0.42. The level of OPG mRNA expression was lower in the glucocorticoid group than in the control group; the level of RANKL mRNA expression was increased in the glucocorticoid group, whose OPG /RANKL ratio decreased significantly (P<0.05). The alendronate and control groups did not differ significantly. Conlusion (1) Glucocorticoid significantly down-regulated the level of OPG mRNA expression and up-regulated RANKL mRNA expression, thus lowering OPG/RANKL ratio. (2) Alendronate prevents glucocorticoid-induced osteonecrosis of femoral head, which may be correlated to alendronate's counteracting with glucocorticiod in the regulation of expressions of OPG and RANKL mRNA.

Administration of erythropoietin prevents bone loss in osteonecrosis of the femoral head in mice

Administration of erythropoietin exerts protective effects against glucocorticoid-induced osteonecrosis of the femoral head in rats

Erythropoietin Prevents Rats from Glucocorticoid-Induced Osteonecrosis of the Femoral Head Via Anti-Apoptosis

Erythropoietin Enhances Bone Repair Effects Via the Hypoxia-Inducible Factor Signal Pathway in Glucocorticoid-Induced Osteonecrosis of the Femoral Head.

Erythropoietin suppresses osteoblast apoptosis and ameliorates steroid-induced necrosis of the femoral head in rats by inhibition of STAT1-caspase 3 signaling pathway

Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss

Effects of hypoxia environment on osteonecrosis of the femoral head in Sprague-Dawley rats

Erythropoietin directly stimulates osteoclast precursors and induces bone loss

Effects of alendronate on expression levels of OPG and RANKL mRNAs in bone tissues of femoral head of rats receiving long-term glucocorticoid administration

The effect of deferoxamine on angiogenesis and bone repair in steroid-induced osteonecrosis of rabbit femoral heads

Administration of mircoRNA‐135b‐reinforced exosomes derived from MSCs ameliorates glucocorticoid‐induced osteonecrosis of femoral head (ONFH) in rats

Repairing defect and preventing collapse of femoral head in a steroid-induced osteonecrotic of femoral head animal model using strontium-doped calcium polyphosphate combined BM-MNCs

Effect of long-term administration of glucocorticoid on expression level of OPG/RANKL mRNAs in bone tissues of femoral head of rats

Alendronate Alleviated Femoral Head Necrosis And Upregulated Bmp2/Eif2ak3/Eif2a/Atf4 Pathway In Liquid Nitrogen Treated Rats

PTEN inhibitor VO-OHpic attenuates GC-associated endothelial progenitor cell dysfunction and osteonecrosis of the femoral head via activating Nrf2 signaling and inhibiting mitochondrial apoptosis pathway

Erythropoietin enhances meniscal regeneration and prevents osteoarthritis formation in mice

Erythropoietin in bone homeostasis—Implications for efficacious anemia therapy

Stromal-Cell-Derived Factor (SDF) 1-Alpha Overexpression Promotes Bone Regeneration by Osteogenesis and Angiogenesis in Osteonecrosis of the Femoral Head

[Effect of Epimedium Extract on Osteoprotegerin and RANKL Mrna Expressions in Glucocorticoid-Induced Femoral Head Necrosis in Rats].

Dimethyloxalylglycine Attenuates Steroid-Associated Endothelial Progenitor Cell Impairment and Osteonecrosis of the Femoral Head by Regulating the HIF-1α Signaling Pathway

Hypoxia Enhanced Bone Regeneration Through the HIF-1α/β-Catenin Pathway in Femoral Head Osteonecrosis